Type I and type III collagen metabolites in adult osteosarcoma patients
1996

Collagen Metabolites in Osteosarcoma Patients

Sample size: 39 publication Evidence: moderate

Author Information

Author(s): T Wiklund, C Blomqvist, L Risteli, J Risteli, E Karaharju, I Elomaal

Primary Institution: University of Helsinki

Hypothesis

The study investigates the relationship between collagen metabolites and outcomes in osteosarcoma patients.

Conclusion

The study found that collagen metabolites did not predict outcomes in osteosarcoma patients, and their levels changed inconsistently with disease progression.

Supporting Evidence

  • Collagen metabolites were measured in 39 osteosarcoma patients.
  • Elevated concentrations of type I and III collagen metabolites were frequent in untreated osteogenic sarcoma.
  • None of the collagen metabolites were prognostic factors for survival at baseline.

Takeaway

Doctors looked at special proteins in the blood of young people with bone cancer to see if they could tell how sick they were, but they found that these proteins didn't really help.

Methodology

The study measured three collagen metabolites in serum samples from osteosarcoma patients before and after treatment.

Limitations

The study's findings may not apply to older patients as the majority were young.

Participant Demographics

The mean age of patients was 22 years, with a range from 15 to 55 years, and included both men and women.

Statistical Information

P-Value

0.02

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication